Table 3.
Ongoing treatment studies evaluating EGFR MoAbs in cervical cancer patients.
| Protocol number | Disease stage | Target therapy | Adjuvant treatment | Study phase | PI |
|---|---|---|---|---|---|
| NCT00803062 | Stage IVb/ | Bevacizumab | Cisplatin/topotecan hydrochloride/paclitaxel | Phase III | Krishnansu Tewari, MD |
| recurrent/persistent | |||||
| NCT00548418 | Recurrent/Persistent | Bevacizumab | Topotecan/cisplatin | Phase II | Janet S Rader, MD |